学术探索
学术期刊
新闻热点
数据分析
智能评审

HER2/neu in the management of invasive breast cancer

被引：38
作者：
Meric, F
Hung, MC
Hortobagyi, GN
Hunt, KK
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA
[3] Univ Texas, MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS | 2002年 / 194卷 / 04期
关键词：
D O I：
10.1016/S1072-7515(02)01121-3
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：488 / 501
页数：14
相关论文
共 131 条
[1]   HER-2/NEU IN NODE-NEGATIVE BREAST-CANCER - PROGNOSTIC-SIGNIFICANCE OF OVEREXPRESSION INFLUENCED BY THE PRESENCE OF INSITU CARCINOMA [J].
ALLRED, DC ;
CLARK, GM ;
TANDON, AK ;
MOLINA, R ;
TORMEY, DC ;
OSBORNE, CK ;
GILCHRIST, KW ;
MANSOUR, EG ;
ABELOFF, M ;
EUDEY, L ;
MCGUIRE, WL .
JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (04) :599-605
[2]   ASSOCIATION OF C-ERBB-2 EXPRESSION AND S-PHASE FRACTION IN THE PROGNOSIS OF NODE POSITIVE BREAST-CANCER [J].
ANBAZHAGAN, R ;
GELBER, RD ;
BETTELHEIM, R ;
GOLDHIRSCH, A ;
GUSTERSON, BA .
ANNALS OF ONCOLOGY, 1991, 2 (01) :47-53
[3]  
ANIDO J, 2001, M AM SOC CLIN ONC SA
[4]   Phase II study of weekly intravenous recombinant humanized Anti-p185(HER2) monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast [J].
Baselga, J ;
Tripathy, D ;
Mendelsohn, J ;
Baughman, S ;
Benz, CC ;
Dantis, L ;
Sklarin, NT ;
Seidman, AD ;
Hudis, CA ;
Moore, J ;
Rosen, PP ;
Twaddell, T ;
Henderson, IC ;
Norton, L .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (03) :737-744
[5]  
Baselga J, 1998, CANCER RES, V58, P2825
[6]  
Bergman I, 2001, CLIN CANCER RES, V7, P2050
[7]   HER-2/neu and p53 expression versus tamoxifen resistance in estrogen receptor-positive, node-positive breast cancer [J].
Berry, DA ;
Muss, HB ;
Thor, AD ;
Dressler, L ;
Liu, ET ;
Broadwater, G ;
Budman, DR ;
Henderson, IC ;
Barcos, M ;
Hayes, D ;
Norton, L .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (20) :3471-3479
[8]  
Birner P, 2001, CLIN CANCER RES, V7, P1669
[9]  
BORG A, 1990, CANCER RES, V50, P4332
[10]  
BRYSCH W, 1994, CANCER GENE THER, V1, P99
12345678910